Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	Ank_2	TANC2 ANKRD31 CTTNBP2 ANKRD27 KIDINS220 ZDHHC13 TRPA1 ANK3 DGKZ LRRK1 ZDHHC17 MYO16	2.96e-06	215	196	12	PF12796
Domain	Ank	TANC2 ANKRD31 CTTNBP2 ANKRD27 KIDINS220 ZDHHC13 TRPA1 ANK3 DGKZ LRRK1 ZDHHC17 MYO16	5.42e-06	228	196	12	PF00023
Domain	-	TANC2 ANKRD31 CTTNBP2 ANKRD27 KIDINS220 ZDHHC13 TRPA1 ANK3 DGKZ LRRK1 ZDHHC17 MYO16	1.27e-05	248	196	12	1.25.40.20
Domain	ANK	TANC2 ANKRD31 CTTNBP2 ANKRD27 KIDINS220 ZDHHC13 TRPA1 ANK3 DGKZ LRRK1 ZDHHC17 MYO16	1.43e-05	251	196	12	SM00248
Domain	ANK_REPEAT	TANC2 ANKRD31 CTTNBP2 ANKRD27 KIDINS220 ZDHHC13 TRPA1 ANK3 DGKZ LRRK1 ZDHHC17 MYO16	1.55e-05	253	196	12	PS50088
Domain	Ankyrin_rpt-contain_dom	TANC2 ANKRD31 CTTNBP2 ANKRD27 KIDINS220 ZDHHC13 TRPA1 ANK3 DGKZ LRRK1 ZDHHC17 MYO16	1.61e-05	254	196	12	IPR020683
Domain	ANK_REP_REGION	TANC2 ANKRD31 CTTNBP2 ANKRD27 KIDINS220 ZDHHC13 TRPA1 ANK3 DGKZ LRRK1 ZDHHC17 MYO16	1.61e-05	254	196	12	PS50297
Domain	Ankyrin_rpt	TANC2 ANKRD31 CTTNBP2 ANKRD27 KIDINS220 ZDHHC13 TRPA1 ANK3 DGKZ LRRK1 ZDHHC17 MYO16	2.19e-05	262	196	12	IPR002110
Domain	AlaDh_PNT_C	AASS NNT	1.10e-04	2	196	2	PF01262
Domain	AlaDH/PNT_N	AASS NNT	1.10e-04	2	196	2	IPR007886
Domain	AlaDh_PNT_N	AASS NNT	1.10e-04	2	196	2	PF05222
Domain	AlaDh_PNT_N	AASS NNT	1.10e-04	2	196	2	SM01003
Domain	AlaDh_PNT_C	AASS NNT	1.10e-04	2	196	2	SM01002
Domain	ALADH_PNT_1	AASS NNT	1.10e-04	2	196	2	PS00836
Domain	ALADH_PNT_2	AASS NNT	1.10e-04	2	196	2	PS00837
Domain	AlaDH/PNT_NAD(H)-bd	AASS NNT	1.10e-04	2	196	2	IPR007698
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	DDX19B HK1 CCT3 VPS13C PSMA3 DNAJA2 PSMD7 DBT STT3A GUF1 RPTOR RRP12 SYNE2 NIP7 SLAIN1 SUCO GPD2 TTC28 ACAD9 HUWE1 ZDHHC17 OTC NUP155 AASS SUPT16H ATP1A1 FLOT1 RPA1 NNT	9.57e-09	1496	199	29	32877691
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MON2 CSMD3 KIDINS220 RRP12 SNX27 MCF2L SLC23A2 APPBP2 TTC28 CLASP1 STXBP5 ADGRL1 ALS2 ZDHHC17 MACF1	1.57e-08	407	199	15	12693553
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	HK1 CCT3 VPS13C PSMA3 DNAJA2 PSMD7 PSMD8 DBT STT3A PEF1 KIDINS220 ANAPC1 RPTOR RRP12 AP1M1 GPD2 ACAD9 APOB SEC31A HUWE1 NUP155 SUPT16H CCAR1 ATP1A1 FLOT1 RPA1 NNT	5.21e-08	1425	199	27	30948266
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	MON2 DDX19B ERCC2 PSMA3 PSMD7 TUBGCP2 ANKRD27 KIDINS220 COG1 ANAPC1 RPTOR RRP12 TTC28 HUWE1 NUP155 HLTF MAP2K3	9.02e-08	606	199	17	36538041
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MON2 CCT3 DNAJA2 PSMD7 PSMD8 DBT PTPRB RRP12 SYNE2 MIOS SNX27 SLC39A6 GPD2 ANK3 FBXL14 HUWE1 KMT2D TBC1D31 NUP155 ARVCF SUPT16H RPA1	1.81e-07	1049	199	22	27880917
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	MON2 HK1 CCT3 PSMA3 DNAJA2 PSMD7 TUBGCP2 STAT3 STT3A COG1 RRP12 SYNE2 NIP7 TRAPPC4 COG4 GPD2 ACAD9 HUWE1 NUP155 AASS SUPT16H HLTF CTNNA2 ATP1A1 FLOT1 RPA1	2.39e-07	1440	199	26	30833792
Pubmed	Human transcription factor protein interaction networks.	CCT3 PSMA3 DNAJA2 PSMD7 PSMD8 DBT STAT3 STT3A MYO5C RRP12 SYNE2 NIP7 NPAT HSPG2 RBBP6 MAP3K8 SLC25A36 KMT2D ACTR6 CCAR1 ATP1A1 FLOT1 RPA1 PCCA SORL1	7.41e-07	1429	199	25	35140242
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TANC2 CTTNBP2 CCT3 DNAJA2 ANAPC1 RPTOR SYNE2 MIOS CAMSAP1 ANK3 CLASP1 DGKZ SEC31A HUWE1 ARVCF SUPT16H CCAR1 MACF1 CTNNA2 RPA1	7.89e-07	963	199	20	28671696
Pubmed	SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.	DDX19B CCT3 PSMA3 PSMD7 STT3A COG1 COG4 GPD2 HSPG2 ACAD9 SEC31A HUWE1 SLC25A36 NUP155 ATP1A1 ATP1A3 FLOT1 RPA1 NNT	8.24e-07	878	199	19	37223481
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	SETX HK1 CCT3 PSMA3 DNAJA2 PSMD7 ANKRD27 GUF1 RPTOR RRP12 A2ML1 SNX27 AP1M1 SEC31A HUWE1 NUP155 ARVCF SUPT16H HLTF CCAR1 CCT6B MACF1 RPA1 MAP2K3	9.89e-07	1353	199	24	29467282
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	SGSM1 VPS13C ARMC2 STT3A TMCO4 KIDINS220 PTPRB RPTOR PIP5K1A HSD11B2 MCF2L ZDHHC13 MOCOS DOCK1 UXS1 ANK3 ADGRL1 HUWE1 ATP10A SLC25A36 GUCY1A1 CCAR1 MACF1 MAP2K3 PCCA	1.55e-06	1489	199	25	28611215
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	HK1 CCT3 DNAJA2 PSMD7 RRP12 AP1M1 RBBP6 SEC31A HUWE1 NUP155 SUPT16H CCAR1 CCT6B ATP1A1 ATP1A3 RPA1	1.64e-06	665	199	16	30457570
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MON2 SETX DNAJA2 TUBGCP2 PEF1 ANAPC1 RPTOR TTC28 CLASP1 RBBP6 HUWE1 ZNF546 MACF1 ATP1A1 SORL1	1.72e-06	588	199	15	38580884
Pubmed	SNX27-driven membrane localisation of OTULIN antagonises linear ubiquitination and NF-κB signalling activation.	TANC2 PSMD8 TUBGCP2 ANKRD27 STAT3 KIDINS220 SRSF8 SNX27 PIP5K1A GPD2 ADGRL1 DGKZ	2.12e-06	378	199	12	34315543
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	HK1 CCT3 PSMA3 DNAJA2 PSMD8 STT3A BPNT1 RRP12 SYNE2 A2ML1 PIP5K1A AP1M1 GPD2 CLASP1 LAMP2 SEC31A HUWE1 NUP155 SUPT16H CCAR1 ATP1A1 PCCA NNT	4.06e-06	1367	199	23	32687490
Pubmed	Identification of new ciliary signaling pathways in the brain and insights into neurological disorders.	TRAPPC4 SLC39A6 FGF12 KIT SLC23A2 DENND5B MPP3 ADGRL1 ARVCF ATP1A1 ATP1A3 FLOT1	4.30e-06	405	199	12	38187761
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	CCT3 PSMA3 DNAJA2 PSMD7 PSMD8 TUBGCP2 STAT3 AP1M1 SEC31A HUWE1 NUP155 SUPT16H CCAR1 ATP1A1 RPA1	4.63e-06	638	199	15	33239621
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	MON2 HK1 TUBGCP2 STAT3 ANAPC1 RPTOR PIP5K1A AP1M1 GPD2 ACAD9 SEC31A NUP155 HLTF NNT	4.84e-06	560	199	14	35241646
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	HK1 DNAJA2 PSMD7 PSMD8 DBT STT3A C2CD5 GUF1 KIDINS220 RRP12 SYNE2 NIP7 SLC39A6 PIP5K1A SUCO NPAT ANK3 ACAD9 ZDHHC17 TBC1D31 NUP155 SUPT16H MACF1 FLOT1	5.00e-06	1487	199	24	33957083
Pubmed	A human MAP kinase interactome.	SETX CCT3 KIAA1549L MAP3K10 COG4 DOCK1 RALGDS ANK3 RBBP6 ADGRL1 SEC31A ZDHHC17 MACF1	5.18e-06	486	199	13	20936779
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SETX RPS6KA1 ANKRD27 PIP5K1A AP1M1 COG4 MOCOS RALGDS TTC28 ZDHHC17 NUP155 ARVCF HLTF CCAR1 SORL1	5.78e-06	650	199	15	38777146
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	ERCC2 SETX CCT3 DNAJA2 STAT3 STT3A KIDINS220 SYNE2 PIP5K1A COL12A1 RBBP6 ACAD9 LAMP2 APOB SEC31A NUP155 CCAR1 MACF1 CTNNA2 ATP1A1 FLOT1 RPA1	5.88e-06	1297	199	22	33545068
Pubmed	HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways.	CCT3 PSMA3 DNAJA2 PSMD7 PSMD8 STT3A ANAPC1 RPTOR RRP12 A2ML1 PIP5K1A HUWE1 NUP155 ATP1A1	6.04e-06	571	199	14	37167062
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	C2CD5 KIDINS220 PIK3CA SLC39A6 PIP5K1A ANK3 ADGRL1 SEC31A NUP155 ARVCF MACF1 ATP1A1	6.36e-06	421	199	12	36976175
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	TANC2 DDX19B SETX CCT3 TUBGCP2 ANAPC1 DOCK1 CLASP1 HUWE1 NUP155 HLTF MACF1 RPA1 MAP2K3	7.49e-06	582	199	14	20467437
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TANC2 DDX19B SETX PSMD7 ANKRD27 STAT3 FSIP2 RPTOR SYNE2 MAP3K10 AP1M1 CAMSAP1 TTC28 CLASP1 ALS2 AASS MACF1	1.06e-05	861	199	17	36931259
Pubmed	mTORC1-Regulated and HUWE1-Mediated WIPI2 Degradation Controls Autophagy Flux.	CCT3 RPTOR AP1M1 HUWE1	1.20e-05	25	199	4	30340022
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	RPS6KA1 C2CD5 KIDINS220 SLC39A6 PIP5K1A SLC23A2 ANK3 STXBP5 CTNNA2 ATP1A1 FLOT1	1.25e-05	377	199	11	38117590
Pubmed	The protein interaction landscape of the human CMGC kinase group.	ERCC2 PSMA3 C2CD5 SERPINB10 SRSF8 FGF12 MPP3 RBBP6 HUWE1 GTF2H3 SUPT16H ATP1A1 FLOT1 MAP2K3 SORL1	1.27e-05	695	199	15	23602568
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	MON2 RPS6KA1 PSMA3 PSMD7 PSMD8 STT3A C2CD5 KIDINS220 SNX27 PIP5K1A MPP3 CLASP1 ACAD9 DGKZ HUWE1 NUP155 CCT6B SORL1	1.41e-05	974	199	18	28675297
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	CCT3 STAT3 STT3A KIDINS220 CAMSAP1 DOCK1 GPD2 ANK3 TTC28 LAMP2 SEC31A NUP155 MACF1 ATP1A1 RPA1	1.58e-05	708	199	15	39231216
Pubmed	Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms.	CCT3 RPS6KA1 DNAJA2 ANO5 STAT3 PIK3CA APOB CTNNA2 ATP1A1	1.84e-05	256	199	9	24189400
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	DNAJA2 WDR76 ANAPC1 RRP12 NIP7 PIP5K1A ACTR6 SUPT16H HLTF ATP1A1 RPA1	1.88e-05	394	199	11	27248496
Pubmed	A protein interaction landscape of breast cancer.	ERCC2 HK1 PIK3CA ABRAXAS1 AP1M1 ANK3 TTC28 ACAD9 SEC31A SUPT16H MACF1 CTNNA2 RPA1 NNT	1.94e-05	634	199	14	34591612
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	MON2 VPS13C DNAJA2 TUBGCP2 STT3A PEF1 ANAPC1 MIOS CAMSAP1 COG4 TTC28 CLASP1 HUWE1 TBC1D31 GUCY1B1	2.36e-05	733	199	15	34672954
Pubmed	An Interaction Landscape of Ubiquitin Signaling.	DDX19B ERCC2 PSMD7 PSMD8 DBT ABRAXAS1 SNX27 HSPG2 APPBP2 HUWE1 GTF2H3 MACF1	2.38e-05	481	199	12	28190767
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	ERCC2 CCT3 PSMD7 DBT ANKRD27 STAT3 STT3A GUF1 SRSF8 RRP12 NIP7 AP1M1 RBBP6 HUWE1 ZNF546 SUPT16H HLTF CCAR1 RPA1 MAP2K3 PCCA	2.45e-05	1318	199	21	30463901
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MON2 TANC2 ERCC2 DNAJA2 TUBGCP2 DBT C2CD5 SLC35F3 ANAPC1 RPTOR ZDHHC13 TTC28 RBBP6 SETDB2 ACTR6 SUPT16H MACF1 PCCA SORL1	2.50e-05	1116	199	19	31753913
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	CCT3 STT3A MYO5C KIDINS220 RPTOR RBBP6 RPA1 SORL1	2.85e-05	208	199	8	33230847
Pubmed	Organization of the gene (RHCE) encoding the human blood group RhCcEe antigens and characterization of the promoter region.	RHCE RHD	3.26e-05	2	199	2	8188244
Pubmed	Diacylglycerol kinase zeta regulates phosphatidylinositol 4-phosphate 5-kinase Ialpha by a novel mechanism.	PIP5K1A DGKZ	3.26e-05	2	199	2	15157668
Pubmed	Structural insights into the mechanism of human soluble guanylate cyclase.	GUCY1A1 GUCY1B1	3.26e-05	2	199	2	31514202
Pubmed	DCS-1, DCS-2, and DFV share amino acid substitutions at the extracellular RhD protein vestibule.	RHCE RHD	3.26e-05	2	199	2	17900276
Pubmed	RHD and RHCE molecular analysis in weak D blood donors and in patients with Rh antibodies against their own corresponding Rh antigen.	RHCE RHD	3.26e-05	2	199	2	32697929
Pubmed	Recurrent inflammatory myofibroblastic tumors harboring PIK3CA and KIT mutations.	PIK3CA KIT	3.26e-05	2	199	2	25120743
Pubmed	Review: the molecular basis of the Rh blood group phenotypes.	RHCE RHD	3.26e-05	2	199	2	15373666
Pubmed	Intron 4 of the RH Gene in Han Chinese, Tibetan, and Mongol Populations.	RHCE RHD	3.26e-05	2	199	2	26579938
Pubmed	Regionally distinct patterns of STAT3 phosphorylation in the seminiferous epithelia of mouse testes.	STAT3 KIT	3.26e-05	2	199	2	29393534
Pubmed	PCR screening for common weak D types shows different distributions in three Central European populations.	RHCE RHD	3.26e-05	2	199	2	11161244
Pubmed	Fasudil inhibits tissue factor and plasminogen activator Inhibitor-1 secretion by peripheral blood mononuclear cells in CAPD patients.	F11 HLTF	3.26e-05	2	199	2	27756191
Pubmed	The low-prevalence Rh antigen STEM (RH49) is encoded by two different RHCEce818T alleles that are often in cis to RHDDOL.	RHCE RHD	3.26e-05	2	199	2	22738288
Pubmed	A mechanism for epithelial-mesenchymal transition and anoikis resistance in breast cancer triggered by zinc channel ZIP6 and STAT3 (signal transducer and activator of transcription 3).	STAT3 SLC39A6	3.26e-05	2	199	2	23919497
Pubmed	Multiple Rh messenger RNA isoforms are produced by alternative splicing.	RHCE RHD	3.26e-05	2	199	2	1379850
Pubmed	Characterization of the mouse Rh blood group gene.	RHCE RHD	3.26e-05	2	199	2	10329015
Pubmed	Properties and expression of Na+/K+-ATPase α-subunit isoforms in the brain of the swamp eel, Monopterus albus, which has unusually high brain ammonia tolerance.	ATP1A1 ATP1A3	3.26e-05	2	199	2	24391932
Pubmed	Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population.	LILRB3 LILRA6	3.26e-05	2	199	2	33526815
Pubmed	Dysregulated striatal neuronal processing and impaired motor behavior in mice lacking huntingtin interacting protein 14 (HIP14).	ZDHHC13 ZDHHC17	3.26e-05	2	199	2	24376823
Pubmed	Na+/K+ ATPase α1 and α3 isoforms are differentially expressed in α- and γ-motoneurons.	ATP1A1 ATP1A3	3.26e-05	2	199	2	23761886
Pubmed	ZDHHC17 promotes axon outgrowth by regulating TrkA-tubulin complex formation.	NTRK1 ZDHHC17	3.26e-05	2	199	2	26232532
Pubmed	Determination of the N-terminal sequence of human red cell Rh(D) polypeptide and demonstration that the Rh(D), (c), and (E) antigens are carried by distinct polypeptide chains.	RHCE RHD	3.26e-05	2	199	2	3135863
Pubmed	Sequences and evolution of mammalian RH gene transcripts and proteins.	RHCE RHD	3.26e-05	2	199	2	9811965
Pubmed	Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety.	RHCE RHD	3.26e-05	2	199	2	12393640
Pubmed	The family of human Na+,K+-ATPase genes. A partial nucleotide sequence related to the alpha-subunit.	ATP1A1 ATP1A3	3.26e-05	2	199	2	3030810
Pubmed	Differential expression of alternative transcripts of soluble guanylyl cyclase, GYCY1a3 and GUCY1b3 genes, in the malignant and benign breast tumors.	GUCY1A1 GUCY1B1	3.26e-05	2	199	2	30597209
Pubmed	Isolation of a new cDNA clone encoding an Rh polypeptide associated with the Rh blood group system.	RHCE RHD	3.26e-05	2	199	2	7916743
Pubmed	RHDDOL1 and RHDDOL2 encode a partial D antigen and are in cis with the rare RHCE*ceBI allele in people of African descent.	RHCE RHD	3.26e-05	2	199	2	22690701
Pubmed	The STAT3/SETDB2 axis dictates NF-κB-mediated inflammation in macrophages during wound repair.	STAT3 SETDB2	3.26e-05	2	199	2	39435663
Pubmed	Huntingtin-interacting proteins, HIP14 and HIP14L, mediate dual functions, palmitoyl acyltransferase and Mg2+ transport.	ZDHHC13 ZDHHC17	3.26e-05	2	199	2	18794299
Pubmed	Immunohistochemical analyses of alpha1 and alpha3 Na+/K+-ATPase subunit expression in medulloblastomas.	ATP1A1 ATP1A3	3.26e-05	2	199	2	21498719
Pubmed	Nucleotide sequence, genomic organization, and chromosomal localization of genes encoding the human NMDA receptor subunits NR3A and NR3B.	GRIN3A GRIN3B	3.26e-05	2	199	2	11735224
Pubmed	Altered Regulation of Striatal Neuronal N-Methyl-D-Aspartate Receptor Trafficking by Palmitoylation in Huntington Disease Mouse Model.	ZDHHC13 ZDHHC17	3.26e-05	2	199	2	30846936
Pubmed	Sequence diversity of the Rh blood group system in Basques.	RHCE RHD	3.26e-05	2	199	2	30089826
Pubmed	Colocalization of the genes coding for the alpha 3 and beta 3 subunits of soluble guanylyl cyclase to human chromosome 4 at q31.3-q33.	GUCY1A1 GUCY1B1	3.26e-05	2	199	2	8097486
Pubmed	LITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growth.	TNFSF15 LITAF	3.26e-05	2	199	2	21217782
Pubmed	Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.	PIK3CA KIT	3.26e-05	2	199	2	7691885
Pubmed	Hepatic oxidative stress activates the Gadd45b gene by way of degradation of the transcriptional repressor STAT3.	GADD45B STAT3	3.26e-05	2	199	2	23939942
Pubmed	PI 3-Kinase and the Histone Methyl-Transferase KMT2D Collaborate to Induce Arp2/3-Dependent Migration of Mammary Epithelial Cells.	PIK3CA KMT2D	3.26e-05	2	199	2	38786098
Pubmed	RHCE variants inherited with altered RHD alleles in Brazilian blood donors.	RHCE RHD	3.26e-05	2	199	2	27111588
Pubmed	Alteration of RH gene structure and expression in human dCCee and DCW-red blood cells: phenotypic homozygosity versus genotypic heterozygosity.	RHCE RHD	3.26e-05	2	199	2	8822955
Pubmed	Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese.	RHCE RHD	3.26e-05	2	199	2	12201845
Pubmed	HPV-18E6 Inhibits Interactions between TANC2 and SNX27 in a PBM-Dependent Manner and Promotes Increased Cell Proliferation.	TANC2 SNX27	3.26e-05	2	199	2	36326272
Pubmed	Comprehensive phenotypic and molecular investigation of RhD and RhCE variants in Moroccan blood donors.	RHCE RHD	3.26e-05	2	199	2	30418133
Pubmed	Molecular cloning and primary structure of the human blood group RhD polypeptide.	RHCE RHD	3.26e-05	2	199	2	1438298
Pubmed	Specific amino acid substitutions cause distinct expression of JAL (RH48) and JAHK (RH53) antigens in RhCE and not in RhD.	RHCE RHD	3.26e-05	2	199	2	20233350
Pubmed	Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma.	HK1 STAT3	3.26e-05	2	199	2	26889748
Pubmed	RHDweak partial 4.0 is associated with an altered RHCEce(48C, 105T, 733G, 744C, 1025T) allele in the Tunisian population.	RHCE RHD	3.26e-05	2	199	2	23742316
Pubmed	A comprehensive survey of both RHD and RHCE allele frequencies in sub-Saharan Africa.	RHCE RHD	3.26e-05	2	199	2	24033223
Pubmed	Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair.	LILRB3 LILRA6	3.26e-05	2	199	2	24096970
Pubmed	The large conductance potassium channel beta-subunit can interact with and modulate the functional properties of a calcium-activated chloride channel, CLCA1.	CLCA1 KCNMB1	3.26e-05	2	199	2	11994272
Pubmed	Hypertension reduces soluble guanylyl cyclase expression in the mouse aorta via the Notch signaling pathway.	GUCY1A1 GUCY1B1	3.26e-05	2	199	2	28465505
Pubmed	NGF/TrkA-mediated Kidins220/ARMS signaling activated in the allergic airway challenge in mice.	KIDINS220 NTRK1	3.26e-05	2	199	2	20934630
Pubmed	Molecular cloning of the cDNAs coding for the two subunits of soluble guanylyl cyclase from human brain.	GUCY1A1 GUCY1B1	3.26e-05	2	199	2	1352257
Pubmed	Accurate long-read sequencing allows assembly of the duplicated RHD and RHCE genes harboring variants relevant to blood transfusion.	RHCE RHD	3.26e-05	2	199	2	34968422
Pubmed	Regarding the size of Rh proteins.	RHCE RHD	3.26e-05	2	199	2	1898705
Pubmed	RH diversity in Mali: characterization of a new haplotype RHDDIVa/RHCEceTI(D2).	RHCE RHD	3.26e-05	2	199	2	25857637
Pubmed	All human Na(+)-K(+)-ATPase alpha-subunit isoforms have a similar affinity for cardiac glycosides.	ATP1A1 ATP1A3	3.26e-05	2	199	2	11546672
Pubmed	Role of STAT3 in in vitro transformation triggered by TRK oncogenes.	STAT3 NTRK1	3.26e-05	2	199	2	20209132
Pubmed	Genomic organization of alpha1 and beta1 subunits of the mammalian soluble guanylyl cyclase genes.	GUCY1A1 GUCY1B1	3.26e-05	2	199	2	10984516
Pubmed	Interstitial cells of Cajal mediate nitrergic inhibitory neurotransmission in the murine gastrointestinal tract.	KIT GUCY1B1	3.26e-05	2	199	2	24833707
Pubmed	RHCEceMO is frequently in cis to RHDDAU0 and encodes a hr(S) -, hr(B) -, RH:-61 phenotype in black persons: clinical significance.	RHCE RHD	3.26e-05	2	199	2	23772606
Interaction	PLAC8L1 interactions	CCT3 A2ML1 ZDHHC13 ZDHHC17 CCT6B	8.61e-07	19	196	5	int:PLAC8L1
Interaction	LILRB3 interactions	LRRC34 LILRB3 ANK3 LILRA6	2.71e-06	11	196	4	int:LILRB3
Interaction	SSR2 interactions	ERCC2 TUBGCP2 GUF1 TTC28 ATP1A1 ATP1A3	5.31e-06	46	196	6	int:SSR2
Interaction	GJA1 interactions	MON2 CNST DNAJA2 KIDINS220 COG1 PIK3CA SYNE2 SLC39A6 PIP5K1A DENND5B ANK3 LAMP2 APOB SEC31A HSD3B7 NUP155 MACF1 ATP1A1	1.67e-05	583	196	18	int:GJA1
Interaction	NUP155 interactions	MON2 DDX19B ANO5 STT3A KIDINS220 COG1 SYNE2 SLAIN1 COG4 NTRK1 SEC31A HUWE1 HSD3B7 KMT2D NUP155 RPA1	1.84e-05	477	196	16	int:NUP155
Interaction	RHOF interactions	TANC2 DDX19B TUBGCP2 STT3A C2CD5 KIDINS220 SLC39A6 PIP5K1A ANK3 ADGRL1 NUP155 ARVCF SUPT16H HLTF CCT6B MACF1 ATP1A1 FLOT1 MAP2K3	3.31e-05	673	196	19	int:RHOF
Interaction	FAF2 interactions	VPS13C PSMD8 STT3A KIDINS220 RPTOR GPD2 ACAD9 LAMP2 APOB HUWE1 HSD3B7 NUP155 ATP1A1 RPA1 NNT	3.73e-05	451	196	15	int:FAF2
Interaction	GPR45 interactions	MON2 DDX19B TUBGCP2 STAT3 GUF1 COG1 SLC39A6 COG4 ARVCF AASS HLTF ATP1A3	3.96e-05	300	196	12	int:GPR45
Interaction	COMT interactions	HK1 OTOP3 AP1M1 MYADML2 LITAF SEC31A HSD3B7 RPA1 NNT	4.65e-05	171	196	9	int:COMT
Interaction	C3AR1 interactions	STAT3 ZDHHC13 TCAF2 UXS1 ACAD9 SLC19A2 ZDHHC17	5.52e-05	100	196	7	int:C3AR1
Interaction	DLK1 interactions	ANKRD27 C2CD5 KIDINS220 TCAF2 SLC19A2 ZDHHC17 ATP1A3	5.88e-05	101	196	7	int:DLK1
GeneFamily	Ankyrin repeat domain containing	TANC2 ANKRD31 CTTNBP2 ANKRD27 KIDINS220 ZDHHC13 TRPA1 ANK3 ZDHHC17 MYO16	1.69e-05	242	138	10	403
GeneFamily	Guanylate cyclases, soluble	GUCY1A1 GUCY1B1	3.44e-04	4	138	2	820
GeneFamily	ATPase Na+/K+ transporting subunits	ATP1A1 ATP1A3	1.18e-03	7	138	2	1208
GeneFamily	Glutamate ionotropic receptor NMDA type subunits	GRIN3A GRIN3B	1.18e-03	7	138	2	1201
GeneFamily	Fibronectin type III domain containing	CNTN6 PTPRB USH2A COL12A1 ROS1 SORL1	1.44e-03	160	138	6	555
GeneFamily	Components of oligomeric golgi complex	COG1 COG4	1.57e-03	8	138	2	493
GeneFamily	VPS9 domain containing	ANKRD27 ALS2	2.50e-03	10	138	2	928
GeneFamily	Solute carriers	SLC35F3 SLC39A6 SLC38A11 SLC23A2 SLC25A27 SLC19A2 SLC25A36 SLC15A1 SLC38A6	3.34e-03	395	138	9	752
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	KIT NTRK1 ROS1	3.50e-03	40	138	3	321
GeneFamily	Proteasome	PSMA3 PSMD7 PSMD8	4.30e-03	43	138	3	690
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	TANC2 DOK6 ANO5 CHN1 CSMD3 C2CD5 FSIP2 KIAA1549L NRXN2 FGF12 GPC2 GRIN3A MCF2L MPP3 RALGDS ANK3 STXBP5 ADGRL1 FHOD3 GUCY1A1 CTNNA2 ATP1A3 MAP2K3 PRLR	3.26e-06	1106	197	24	M39071
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	MON2 CTTNBP2 SYNE2 MCF2L TMC1 ANK3 SLC19A2 AASS ATP1A1 PRLR	1.45e-08	189	199	10	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	Bronchial_Biopsy-Immune-Mast_cells\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	ANKRD31 CTTNBP2 PTPRB CCNA1 SLC38A11 KIT NTRK1 ALS2 WSCD2	6.97e-08	168	199	9	45ccc0cb42d21f4853190e8e9ed9a54aefefe738
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 FGF12 SLC38A11 HSD11B2 MOCOS MACC1 ANK3 STXBP5 FHOD3	1.74e-07	187	199	9	e3095455d2f255854f339f6b05fa87852af0700f
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CTTNBP2 AKAP4 SLC38A11 KIT NTRK1 ALS2 HLTF WSCD2 MYO16	1.90e-07	189	199	9	f01158bb15df3117fae1271bf8cf8c2501422671
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAJA2 STAT3 STT3A COL3A1 HSPG2 LAMP2 SEC31A ATP1A1 MAP2K3	2.59e-07	196	199	9	151f1a29a91f8b234e9b6ed062666357a2f69128
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDX19B TSSK6 SLC35F3 RRP12 KCNMB1 GPC2 NTRK1 SLC38A6	7.35e-07	163	199	8	953a7db7e90a913e81002d2141fbbd5f1fdf2197
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CHN1 SLAIN1 MACC1 UXS1 ANK3 HIF3A SLC25A36 ROS1	1.49e-06	179	199	8	815b959ce8721c5ded70c0ca6e318dafc691746e
ToppCell	Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Abcc9_(Mural.Acta2Rgs5.Abcc9)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	KCNMB1 SLC38A11 GPC2 MOCOS COL3A1 TCAF2 RBM46	1.61e-06	126	199	7	2b06adfb00a557bd90ad93719548a49f9ae9edeb
ToppCell	Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Abcc9_(Mural.Acta2Rgs5.Abcc9)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	KCNMB1 SLC38A11 GPC2 MOCOS COL3A1 TCAF2 RBM46	1.61e-06	126	199	7	43e7b226a195ab2068518b3a9ffd2192129e8ae4
ToppCell	critical-Myeloid-Mast_cell\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ANKRD31 CTTNBP2 PTPRB SLC38A11 KIT HSPG2 NTRK1 HLTF	1.62e-06	181	199	8	f0d81ae74d3f32979624a94b2ef93774831a7970
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 FGF12 HSD11B2 MOCOS MACC1 ANK3 STXBP5 FHOD3	1.75e-06	183	199	8	b5ede5a0048c585b73c00e88aeddbcaf669347b1
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CTTNBP2 SLC38A11 KIT NTRK1 ALS2 HLTF WSCD2 MYO16	2.06e-06	187	199	8	bdcef4f3e093c3646b639a189bbe93d6f4c40f3c
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CTTNBP2 SLC38A11 KIT NTRK1 ALS2 HLTF WSCD2 MYO16	2.06e-06	187	199	8	0f7a42c55997e34a0d20e492e16b03e91e965335
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CTTNBP2 SLC38A11 KIT NTRK1 ALS2 HLTF WSCD2 MYO16	2.06e-06	187	199	8	064730fa72f8637c3db3fc34d2e363d2b9a38f1d
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CTTNBP2 SLC38A11 KIT NTRK1 ALS2 HLTF WSCD2 MYO16	2.06e-06	187	199	8	09348f1e8bbbca8dca885461937b9b1dd248b034
ToppCell	Mast_cells\|World / lung cells shred on cell class, cell subclass, sample id	CTTNBP2 KCNMB1 SLC38A11 KIT NTRK1 ALS2 HLTF WSCD2	2.15e-06	188	199	8	229d24b87e945c4d543d11ac70761e45175ba0e5
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	MON2 VPS13C KIDINS220 LAMP2 HUWE1 ZDHHC17 NUP155 MACF1	2.41e-06	191	199	8	9454f642c3621370fa23640b631301346b300950
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHN1 KCNMB1 SLC38A11 ADGRL1 ARVCF GUCY1A1 GUCY1B1 WSCD2	2.51e-06	192	199	8	eb9a0b3d32f90f8b95905c740aab21639dae5cbd
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Mast_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CTTNBP2 SLC38A11 KIT STXBP5 NTRK1 ALS2 WSCD2 MYO16	3.40e-06	200	199	8	96540be0e906bbc626049a41978be3dc051d2024
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CTTNBP2 SLC38A11 KIT STXBP5 NTRK1 ALS2 WSCD2 MYO16	3.40e-06	200	199	8	8943278190f42016ee914e584d1b6b9aeaf7c73f
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CTTNBP2 SLC38A11 KIT STXBP5 NTRK1 ALS2 WSCD2 MYO16	3.40e-06	200	199	8	41d7736427494cb30a2f23722ea2b86ff308cfd8
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Mast_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CTTNBP2 SLC38A11 KIT STXBP5 NTRK1 ALS2 WSCD2 MYO16	3.40e-06	200	199	8	ea52df18400550b65de142d03b3b0963436e03d9
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BAAT CSMD3 CNTN6 KIAA1549L USH2A ROS1 PRLR	8.51e-06	162	199	7	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	CSMD3 CNTN6 USH2A DNAH3 SPATA16 CTNNA2 MYO16	8.86e-06	163	199	7	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CTTNBP2 KCNMB1 SLC38A11 KIT STXBP5 ALS2 WSCD2	9.59e-06	165	199	7	640bb71e74a61df2fcb01ceeabe4c493ef836b21
ToppCell	nucseq-Immune-Hematopoietic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CTTNBP2 KCNMB1 SLC38A11 KIT STXBP5 ALS2 WSCD2	9.59e-06	165	199	7	f3df74b5763130c71c0a482a3a23f6b22acc2892
ToppCell	Mild-Myeloid-Mast\|Mild / Condition, Lineage, Cell class and cell subclass	CTTNBP2 PTPRB KIT HSPG2 NTRK1 RHCE WSCD2	9.59e-06	165	199	7	5fa9552c37890c5cc7e672a47038aebba2413cb4
ToppCell	Mild-Myeloid-Mast-\|Mild / Condition, Lineage, Cell class and cell subclass	CTTNBP2 PTPRB KIT HSPG2 NTRK1 RHCE WSCD2	9.59e-06	165	199	7	93d3909a0f5f43d473d5005c842d7d73e25eceed
ToppCell	critical-Myeloid-Mast_cell\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CTTNBP2 PTPRB KCNMB1 SLC38A11 KIT NTRK1 MYO16	9.59e-06	165	199	7	34a1cc6ccd46c059354e8fbde1ac69f202695a4e
ToppCell	nucseq-Immune-Hematopoietic-Granulocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CTTNBP2 KCNMB1 SLC38A11 KIT STXBP5 ALS2 WSCD2	9.59e-06	165	199	7	37615622c736e43260c38016e7c9e565ac97a3e8
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANKRD31 CTTNBP2 SLC38A11 KIT NTRK1 HLTF WSCD2	1.04e-05	167	199	7	0aa1973141a2437df24c9857cd50ff3dfc7673c0
ToppCell	NS-critical-d_07-13-Myeloid-Mast_cell\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CTTNBP2 PTPRB KCNMB1 SLC38A11 KIT NTRK1 MYO16	1.04e-05	167	199	7	8a14fd980d8ebe8ef0216221f619d31aaa27ff15
ToppCell	Control-Mast_cells\|Control / group, cell type (main and fine annotations)	CTTNBP2 KCNMB1 SLC38A11 KIT STXBP5 ALS2 WSCD2	1.12e-05	169	199	7	fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb
ToppCell	COVID-19-lung-MAST\|lung / Disease (COVID-19 only), tissue and cell type	CTTNBP2 SLC38A11 KIT STXBP5 NTRK1 ALS2 WSCD2	1.17e-05	170	199	7	e90f18e5462381b38e918442b38b1c8105291908
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CNST RPTOR COL3A1 COL12A1 WSCD2 RBM46 SLC38A6	1.17e-05	170	199	7	b1a16600754e0c12f7d39c9221f1b03135833f16
ToppCell	Control-Mast_cells-Mast_cells\|Control / group, cell type (main and fine annotations)	CTTNBP2 KCNMB1 SLC38A11 KIT STXBP5 ALS2 WSCD2	1.17e-05	170	199	7	c80f6d29096c372da95a8407f402349ff1bb7018
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CSMD3 POLN GRIN3B SUCO KIT TCAF2 HSD3B7	1.26e-05	172	199	7	a03f30a996a9474ad4cccd209476423a042df002
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related-ICC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CSMD3 POLN GRIN3B SUCO KIT TCAF2 HSD3B7	1.26e-05	172	199	7	f92a53ad2e464cd68ba1714bcc1d5911479cdf1c
ToppCell	moderate-Myeloid-Mast_cell\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CTTNBP2 KCNMB1 SLC38A11 KIT NTRK1 ADGRL1 HLTF	1.41e-05	175	199	7	bbd2971bc6d69e507f90a637834d0936c205c590
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TANC2 MYO5C MCF2L MACC1 ANK3 MACF1 SORL1	1.63e-05	179	199	7	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	facs-Heart-RA-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNMB1 SLC38A11 EBF4 ADGRL1 ARVCF GUCY1A1 GUCY1B1	1.63e-05	179	199	7	d76a05f1fee7f2f7b7b7994d3622e96f02b49432
ToppCell	facs-Heart-RA-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNMB1 SLC38A11 EBF4 ADGRL1 ARVCF GUCY1A1 GUCY1B1	1.63e-05	179	199	7	6be47c877250968a916c711ba0787eb7b4c5443d
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DOK6 FSIP2 SLC35F3 KIT FHOD3 ATP1A1 PRLR	1.75e-05	181	199	7	6aef84616e8d2faf54b7e9e6cd02f33c3066dabc
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DOK6 FSIP2 SLC35F3 KIT FHOD3 ATP1A1 PRLR	1.75e-05	181	199	7	40df0afcb6848202da54670e84f22d7c3a515d01
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DOK6 FSIP2 SLC35F3 KIT FHOD3 ATP1A1 PRLR	1.75e-05	181	199	7	2b53a65ca5616a7b9f64232c3e0b7212d1e2f063
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FGF12 SLC38A11 HSD11B2 SLC23A2 MOCOS MACC1 ANK3	1.75e-05	181	199	7	b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DOK6 FSIP2 SLC35F3 KIT FHOD3 ATP1A1 PRLR	1.75e-05	181	199	7	40d3829ae4aaf81e8616c3499ff8933137fc1cc4
ToppCell	COVID-19-kidney-CD-IC-B\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CSMD3 SLC35F3 SLC38A11 HSD11B2 TMEM116 LITAF NTRK1	1.81e-05	182	199	7	ee6a8c356bbbdae55e4ea858337e079491f9f4aa
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FGF12 HSD11B2 SLC23A2 MOCOS STXBP5 FHOD3 MYO16	1.81e-05	182	199	7	f96095b81188b52db8fcfca4837129cfcd9bd7b7
ToppCell	COVID-19_Mild-immature_Neutrophil\|COVID-19_Mild / Disease condition and Cell class	CEACAM8 WDR76 BPI FHOD3 PCDH20 MYO16	1.92e-05	123	199	6	a6670825fd8d9f9a0111a7b68598c764c99abb0d
ToppCell	COVID-19_Mild-immature_Neutrophil-\|COVID-19_Mild / Disease condition and Cell class	CEACAM8 WDR76 BPI FHOD3 PCDH20 MYO16	1.92e-05	123	199	6	5f19b0e32509bedeb9ac6c74ac7a20750798da5e
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANO5 CSMD3 USH2A COL12A1 APOB ROS1 MYO16	1.94e-05	184	199	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CNTN6 MYO5C SYNE2 MOCOS MPP3 HSPG2 MACC1	1.94e-05	184	199	7	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	IPF-Myeloid-Mast\|World / Disease state, Lineage and Cell class	CTTNBP2 CNST KCNMB1 SLC38A11 KIT NTRK1 ALS2	1.94e-05	184	199	7	7aefa182acad5a53c730945fec85329d7168606a
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANO5 CSMD3 USH2A COL12A1 APOB ROS1 MYO16	1.94e-05	184	199	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANO5 CSMD3 USH2A COL12A1 APOB ROS1 MYO16	1.94e-05	184	199	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 MYO5C SLAIN1 MPP3 MACC1 ANK3 ROS1	1.94e-05	184	199	7	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ANO5 MYO5C SLC35F3 SLC38A11 HSD11B2 MACC1 SORL1	1.94e-05	184	199	7	fa4915b0498f3069fd5ef497286445528f75187e
ToppCell	droplet-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGSM1 CLCA1 NRXN2 UXS1 ACAD9 ALS2 ZDHHC17	2.01e-05	185	199	7	6a85399cfdb9b89683c874e7f046957f9a601dc2
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	MON2 VPS13C KIDINS220 HUWE1 KMT2D NUP155 MACF1	2.01e-05	185	199	7	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	facs-Heart-RA-24m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSSK6 NRXN2 KCNMB1 SLC38A11 ADGRL1 GUCY1A1 GUCY1B1	2.01e-05	185	199	7	10ddf38d908525b4258f9d2da8be4c56ebc08ff4
ToppCell	droplet-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGSM1 CLCA1 NRXN2 UXS1 ACAD9 ALS2 ZDHHC17	2.01e-05	185	199	7	64791056cdbb739136dbef08f4b16e2b5427faad
ToppCell	facs-Heart-RA-24m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSSK6 NRXN2 KCNMB1 SLC38A11 ADGRL1 GUCY1A1 GUCY1B1	2.01e-05	185	199	7	c4ef8d9f8b9769e887daac4efd9dc05738b28ae2
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNMB1 SLC38A11 ANK3 ARVCF GUCY1A1 GUCY1B1 WSCD2	2.01e-05	185	199	7	30df02fbe2828e3c4f3e5c4cda855e74fb31be39
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	MON2 VPS13C KIDINS220 CLASP1 HUWE1 NUP155 MACF1	2.08e-05	186	199	7	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 MYO5C SLAIN1 MPP3 MACC1 ANK3 ROS1	2.08e-05	186	199	7	e83718fabb057100835d3357df407f283d23fe16
ToppCell	COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	CHN1 PTPRB KIAA1549L MCF2L HSPG2 HIF3A OTC	2.16e-05	187	199	7	2d20193a6cacdfa4877457c97b0077408942186c
ToppCell	droplet-Kidney-nan-18m-Epithelial\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BPNT1 ANK3 LAMP2 APOB AASS ATP1A1 PRLR	2.16e-05	187	199	7	236e9857729670e87eed30fad58f49e1f56e4a85
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 MYO5C SLAIN1 MOCOS MPP3 MACC1 ANK3	2.23e-05	188	199	7	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FGF12 SLC38A11 HSD11B2 KIT MOCOS MACC1 ANK3	2.23e-05	188	199	7	58ccb31cdf43167872ef0fc737e6f9c51ee2e060
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FGF12 SLC38A11 HSD11B2 MOCOS MACC1 ANK3 FHOD3	2.31e-05	189	199	7	3a295c215b5c18e7c673f92b7af5be523421682c
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHN1 KCNMB1 SLC38A11 PGLYRP4 ARVCF GUCY1A1 GUCY1B1	2.31e-05	189	199	7	de51fbd6fdb24fc4549393cf41a020005444b2aa
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FGF12 SLC38A11 HSD11B2 SLC23A2 MOCOS MACC1 ANK3	2.31e-05	189	199	7	c9565e962a13a7713056ec3dbb1b67d24f9889c7
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MYO5C SLAIN1 SLC38A11 HSD11B2 MACC1 PRLR SORL1	2.39e-05	190	199	7	625c08a0e5227efc46daa512fd579c3938ff76c7
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SGSM1 CLCA1 NRXN2 FGF12 HSPG2 GUCY1B1 CCT6B	2.39e-05	190	199	7	f50b9814a1beac67dc042a8c27dfd085ceeda3a6
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	KIDINS220 GRIN3A ANK3 GUCY1A1 GUCY1B1 ATP1A1 ATP1A3	2.39e-05	190	199	7	6e92c78799f34b31d098854503c796edb0dc7f80
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SGSM1 CLCA1 NRXN2 FGF12 HSPG2 GUCY1B1 CCT6B	2.39e-05	190	199	7	a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHN1 KCNMB1 SLC38A11 PGLYRP4 ARVCF GUCY1A1 GUCY1B1	2.39e-05	190	199	7	1d8e169d2448a34180c415843bb49aa45ed540c5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 FGF12 SLC38A11 HSD11B2 MOCOS MACC1 ANK3	2.39e-05	190	199	7	11d3c31167ea71809b4cc3757a0c6ea54a448602
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SGSM1 CLCA1 NRXN2 FGF12 HSPG2 GUCY1B1 CCT6B	2.39e-05	190	199	7	57c136bf6d7feafb4a220877bed0cc8fdf314db2
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHN1 KCNMB1 SLC38A11 ARVCF GUCY1A1 GUCY1B1 WSCD2	2.47e-05	191	199	7	5c1f5b6c115b1b27b4a7467a6550ce43c01cf6d0
ToppCell	control-Myeloid-Mast_cell\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CTTNBP2 KIT HSPG2 STXBP5 NTRK1 FBXL14 HLTF	2.47e-05	191	199	7	afebdc59a1f884ce3f2f5fe040e16b0e95e4e7c5
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	MON2 STAT3 RRP12 SYNE2 ANK3 MACF1 SORL1	2.55e-05	192	199	7	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MYO5C SLC35F3 SLAIN1 HSD11B2 MOCOS MACC1 SORL1	2.55e-05	192	199	7	d3634574b2e8d2ded6446969361b70761b331aea
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE2 DENND5B ANK3 TTC28 FHOD3 MACF1 PCCA	2.55e-05	192	199	7	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KCNMB1 COL3A1 HSPG2 FHOD3 ADAMTS5 GUCY1A1 GUCY1B1	2.55e-05	192	199	7	2cc712186e37fb21a964c032765c36a8b4a852cf
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC39A6 FGF12 SLC38A11 HSD11B2 MOCOS MACC1 ANK3	2.64e-05	193	199	7	e7012f7b53971972299db34fa51ff51a4e4987fe
ToppCell	Monocytes-Tissue-resident_macrophages\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	TANC2 KCNMB1 MCF2L MACC1 LITAF FLOT1 SORL1	2.64e-05	193	199	7	198552810dcac8d0ca63a78badd6702b49ff6edf
ToppCell	droplet-Liver-LIVER-NPC-1m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLCA1 COL3A1 ANK3 ADAMTS5 ARVCF GUCY1A1 GUCY1B1	2.73e-05	194	199	7	7942bc83c1bdca687795b91aa232824d603f9b09
ToppCell	5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CLCA1 PDIA2 COL3A1 MACC1 APOB OTC PRLR	2.73e-05	194	199	7	2f6e62a4ec8707bd5a16c0734c5131af55207ea2
ToppCell	droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLCA1 COL3A1 ANK3 ADAMTS5 ARVCF GUCY1A1 GUCY1B1	2.73e-05	194	199	7	415801a3dfacf05f2b603fb424df3d045190a812
ToppCell	droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLCA1 COL3A1 ANK3 ADAMTS5 ARVCF GUCY1A1 GUCY1B1	2.73e-05	194	199	7	256cb33ec90328f2704921fb0fe0fd9812e138b0
ToppCell	3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANKRD31 CTTNBP2 KCNMB1 SLC38A11 KIT NTRK1 HLTF	2.73e-05	194	199	7	9d7f232ef5f27c28f325edfa6614f479013acbba
ToppCell	LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CBLIF AKAP4 SLC35F3 SLC38A11 KIT NTRK1	2.99e-05	133	199	6	81189e8516a431d5890a0909f9fc7c82ec3442bc
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CNTN6 MYO5C SYNE2 MPP3 TMC1 ANK3 ATP1A1	3.01e-05	197	199	7	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	distal-2-mesenchymal-Vascular_Smooth_Muscle\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CHN1 COL3A1 COL12A1 APOB ADAMTS5 GUCY1A1 GUCY1B1	3.11e-05	198	199	7	ce05ede69c167b2294630709bb0c223483a6ef75
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	TANC2 SETX VPS13C SYNE2 KIT SEC31A SORL1	3.21e-05	199	199	7	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	TANC2 SETX VPS13C SYNE2 KIT RBBP6 SEC31A	3.21e-05	199	199	7	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	MON2 DOCK1 ANK3 TTC28 CLASP1 STXBP5 PCCA	3.21e-05	199	199	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil\|COVID-19_Mild / Disease, condition lineage and cell class	CEACAM8 WDR76 SERPINB10 BPI DNAH3 STXBP5 MYO16	3.21e-05	199	199	7	e222b90caf45904d8f763574e7b6aac13333df92
Disease	Anemia, Hemolytic, Congenital	RHCE RHD	4.39e-05	2	196	2	C0002881
Disease	Intellectual Disability	TANC2 HK1 STT3A NRXN2 TRAPPC4 SNX27 RALGDS AASS SUPT16H MACF1 CTNNA2 ATP1A1	4.89e-05	447	196	12	C3714756
Disease	male infertility (implicated_via_orthology)	ARMC2 KIT SPATA16	7.86e-05	13	196	3	DOID:12336 (implicated_via_orthology)
Disease	Fetal Alcohol Spectrum Disorders	RPS6KA1 PIK3CA ANK3	7.86e-05	13	196	3	C2985290
Disease	Rh Deficiency Syndrome	RHCE RHD	1.31e-04	3	196	2	C0272052
Disease	breast angiosarcoma (is_implicated_in)	PTPRB PIK3CA	1.31e-04	3	196	2	DOID:4511 (is_implicated_in)
Disease	Rh-Null, Regulator Type	RHCE RHD	1.31e-04	3	196	2	C1849387
Disease	mean corpuscular hemoglobin concentration	HK1 CCT3 RPS6KA1 PSMA3 STAT3 STT3A PIK3CA PDIA2 PIP5K1A SLC23A2 APPBP2 TTC28 CLASP1 RHCE RHD MACF1 RPA1 MAP2K3 MYO16	1.54e-04	1105	196	19	EFO_0004528
Disease	Fetal Alcohol Syndrome	RPS6KA1 PIK3CA ANK3	1.83e-04	17	196	3	C0015923
Disease	hemoglobin A1 measurement	HK1 CCT3 RPS6KA1 WDR76 ANKRD27 MYO5C SYNE2 LCORL ARVCF WSCD2 MACF1 MAP2K3	2.02e-04	520	196	12	EFO_0007629
Disease	cerebral microbleeds	HSPG2 LCORL CTNNA2	2.59e-04	19	196	3	EFO_0010059
Disease	angiosarcoma (is_implicated_in)	STAT3 PTPRB	2.61e-04	4	196	2	DOID:0001816 (is_implicated_in)
Disease	intrahepatic cholestasis (is_implicated_in)	ABCB4 HSD3B7	2.61e-04	4	196	2	DOID:1852 (is_implicated_in)
Disease	Usher syndrome (is_implicated_in)	USH2A USH1C	2.61e-04	4	196	2	DOID:0050439 (is_implicated_in)
Disease	complex cortical dysplasia with other brain malformations (is_implicated_in)	CAMSAP1 CTNNA2	2.61e-04	4	196	2	DOID:0090131 (is_implicated_in)
Disease	caudate nucleus measurement, functional brain measurement, response to reward	DOK6 CSMD3 CNTN6 MYO16	2.69e-04	47	196	4	EFO_0007849, EFO_0008387, EFO_0008396
Disease	Global developmental delay	TRIT1 HK1 STT3A SNX27 SUPT16H CTNNA2	2.71e-04	133	196	6	C0557874
Disease	cognitive inhibition measurement	CNST A2ML1 USH2A WSCD2	3.42e-04	50	196	4	EFO_0007969
Disease	Partial Fetal Alcohol Syndrome	RPS6KA1 ANK3	4.33e-04	5	196	2	C3661483
Disease	Alcohol Related Neurodevelopmental Disorder	RPS6KA1 ANK3	4.33e-04	5	196	2	C0814154
Disease	venous thromboembolism, tissue plasminogen activator measurement	F11 STXBP5 DGKZ	4.63e-04	23	196	3	EFO_0004286, EFO_0004791
Disease	Alzheimer disease, age at onset	CSMD3 RPTOR CAMSAP1 USH2A MPP3 HSPG2 COL12A1 ARVCF MYO16	5.10e-04	343	196	9	EFO_0004847, MONDO_0004975
Disease	cholesteryl esters to total lipids in large VLDL percentage	ANKRD31 MPP3 TMEM116 APOB	5.29e-04	56	196	4	EFO_0022250
Disease	leukocyte immunoglobulin-like receptor subfamily B member 3 measurement	LILRB3 LILRA6	6.47e-04	6	196	2	EFO_0802705
Disease	Hirschsprung's disease (is_marker_for)	KIT NTRK1	6.47e-04	6	196	2	DOID:10487 (is_marker_for)
Disease	leukocyte immunoglobulin-like receptor subfamily A member 6 measurement	LILRB3 LILRA6	6.47e-04	6	196	2	EFO_0801767
Disease	Alcohol Related Birth Defect	RPS6KA1 ANK3	6.47e-04	6	196	2	C3146244
Disease	Lissencephaly	MACF1 CTNNA2	6.47e-04	6	196	2	C0266463
Disease	familial hemiplegic migraine (implicated_via_orthology)	ATP1A1 ATP1A3	9.02e-04	7	196	2	DOID:0060178 (implicated_via_orthology)
Disease	remission	RPTOR HSPG2	9.02e-04	7	196	2	EFO_0009785
Disease	factor VIII measurement, venous thromboembolism	F11 STXBP5 DGKZ	1.48e-03	34	196	3	EFO_0004286, EFO_0004630
Disease	cholestasis (implicated_via_orthology)	ABCB4 LAMP2	1.53e-03	9	196	2	DOID:13580 (implicated_via_orthology)
Disease	Hypertensive disease	F11 KCNMB1 HSD11B2 COL3A1 GUCY1A1 ATP1A1	1.75e-03	190	196	6	C0020538
Disease	Malignant neoplasm of breast	STAT3 CNTN6 PIK3CA ABRAXAS1 SYNE2 NIP7 SLC39A6 AP1M1 GPC2 KIT PCDH20 RHD ZNF546 KMT2D MACF1 SORL1	2.28e-03	1074	196	16	C0006142
Disease	cup-to-disc ratio measurement	CTTNBP2 KIAA1549L TMEM184B COL12A1 ANK3 TTC28 FHOD3 CCAR1 MYO16	2.44e-03	430	196	9	EFO_0006939
Disease	myocardial infarction	ANKRD31 DOK6 CTTNBP2 STAT3 APOB SLC15A1 GUCY1A1 GUCY1B1	2.46e-03	350	196	8	EFO_0000612
Disease	Cutaneous Melanoma	ERCC2 PIK3CA KIT	2.56e-03	41	196	3	C0151779
Disease	nervous system disease (implicated_via_orthology)	ATP1A1 ATP1A3	2.77e-03	12	196	2	DOID:863 (implicated_via_orthology)
Disease	phosphatidylcholine measurement	CBLIF NRXN2 SYNE2 SLAIN1 APOB MACF1 PRLR	3.01e-03	284	196	7	EFO_0010226
Disease	glioblastoma (is_marker_for)	STAT3 PTPRB MAP2K3	3.13e-03	44	196	3	DOID:3068 (is_marker_for)
Disease	cholesterol to total lipids in large VLDL percentage	ANKRD31 TMEM116 APOB	3.34e-03	45	196	3	EFO_0022236
Disease	Seizures	TANC2 DBT TRAPPC4 SNX27 MACF1 ATP1A1	3.46e-03	218	196	6	C0036572
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	ANKRD31 SYNE2 MPP3 TMEM116 APOB MACF1	3.78e-03	222	196	6	EFO_0008317, EFO_0020943
Disease	Neoplasm of lung	PIK3CA MAP3K8	3.79e-03	14	196	2	cv:C0024121
Disease	Lung cancer	PIK3CA MAP3K8	3.79e-03	14	196	2	cv:C0242379
Disease	LUNG CANCER	PIK3CA MAP3K8	3.79e-03	14	196	2	211980
Disease	Adenocarcinoma of large intestine	PIK3CA KIT NTRK1 ROS1	3.90e-03	96	196	4	C1319315
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	ARMC2 STAT3 SYNE2 MPP3 APOB MACF1	3.95e-03	224	196	6	EFO_0004530, EFO_0008317
Disease	hearing impairment	TRAPPC4 USH2A TMC1 USH1C	4.19e-03	98	196	4	C1384666
Disease	cholesteryl esters to total lipids in small VLDL percentage	ANKRD31 TMEM116 APOB	4.25e-03	49	196	3	EFO_0022256
Disease	T-Cell Lymphoma	STAT3 KMT2D	4.95e-03	16	196	2	C0079772
Disease	Squamous cell carcinoma of the head and neck	STAT3 PIK3CA CCNA1	5.02e-03	52	196	3	C1168401
Disease	bipolar disorder	RPTOR FGF12 KIT ANK3 CLASP1 HUWE1 KMT2D WSCD2 CTNNA2 RPA1	5.44e-03	577	196	10	MONDO_0004985
Disease	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	PTPRB LITAF HIF3A	5.58e-03	54	196	3	EFO_0000180, EFO_0003100, GO_0061479
Disease	Amyotrophic lateral sclerosis	SETX ALS2	5.59e-03	17	196	2	cv:C0002736
Disease	Diffuse Large B-Cell Lymphoma	PIK3CA SEC31A KMT2D	5.88e-03	55	196	3	C0079744
Disease	ovarian cancer (is_implicated_in)	STAT3 PIK3CA APOB	6.18e-03	56	196	3	DOID:2394 (is_implicated_in)
Disease	factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement	F11 MCF2L STXBP5	6.18e-03	56	196	3	EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791
Disease	progression free survival, ovarian carcinoma	LCORL FHOD3	6.26e-03	18	196	2	EFO_0001075, EFO_0004920
Disease	Disorder of organic acid metabolism	DBT PCCA	6.26e-03	18	196	2	cv:C1263739
Disease	Cholestasis	BAAT SLC23A2 HSD3B7 SORL1	6.30e-03	110	196	4	C0008370
Disease	Schizophrenia	HK1 CBLIF NRXN2 PIK3CA GRIN3A COL3A1 SLC25A27 ANK3 NTRK1 RHD ARVCF CTNNA2 MYO16	6.35e-03	883	196	13	C0036341

Protein segments in the cluster

Peptide	Gene	Start	Entry
EIMAINGKIVTDYTL	USH1C	501	Q9Y6N9
YVSDLVNGLVALMNS	UXS1	301	Q8NBZ7
LMVNVSDISLVDYTK	TNFSF15	226	O95150
LVVANLGMSEQLGYK	ABRAXAS1	166	Q6UWZ7
MTTLVLDNGAYNAKI	ACTR6	1	Q9GZN1
GLSMAIYLKQVTATV	BAAT	241	Q14032
SSAQGIESMLKYVEN	CDY1	521	Q9Y6F8
QDILYGMAVLSVATN	ANO5	731	Q75V66
RNKDLIGSYAMAELV	ARVCF	741	O00192
NMELLLSGVYKSQEA	CSMD3	3536	Q7Z407
ADSISKGLMVYANQV	AKAP4	326	Q5JQC9
LALVDKNIMGYIASL	ALS2	681	Q96Q42
KNIMGYIASLHELAT	ALS2	686	Q96Q42
VYNGAMVDVGSLLQK	CCAR1	1026	Q8IX12
INGKYMISTSETIID	ADAMTS5	786	Q9UNA0
VALDTYEKGQLTSSM	COG4	436	Q9H9E3
MADSAQAQKLVYLVT	HSD3B7	1	Q9H2F3
YAGDVSSSVKLMEQL	ADGRL1	566	O94910
DTGSYTLQVIKLNLM	CEACAM8	116	P31997
MVKINGIYLTKSNAI	ARMC2	171	Q8NEN0
SLTAYVTAALLEMGK	A2ML1	1096	A8K2U0
KRVANILINLYGMTA	ACAD9	531	Q9H845
VMQSATYLLDGKVVN	AASS	661	Q9UDR5
MSASAVYVLDLKGKV	AP1M1	1	Q9BXS5
LMDHGVKVASVLAYS	APPBP2	86	Q92624
AYGTSKAAVALLMDT	HSD11B2	231	P80365
LVASAYSIAQKAGMI	BPNT1	11	O95861
IQALSRKGIYVMESD	CAMSAP1	111	Q5T5Y3
INVYTKGADSVVMDL	ATP10A	761	O60312
KQAAALVITVMYTDG	POLN	216	Q7Z5Q5
NEAALLALMEKTGYN	RBM46	21	Q8TBY0
TVYNTKMASVGLSDI	HSPG2	696	P98160
YQTAELVKMDILLNG	GUF1	546	Q8N442
GLLIIAMVKSNQYLS	KCNMB1	171	Q16558
KMIVSQLSYNAGALT	LITAF	101	Q99732
GKNLTTILNEYVAMK	NPAT	56	Q14207
GATLALAMIYLKTNN	ANAPC1	1366	Q9H1A4
LLVSKGAMVNATDYH	ANKRD27	481	Q96NW4
MKELLRSYGAIETVN	ANKRD31	1266	Q8N7Z5
ITYKASHNIGIAMDT	DBT	336	P11182
DKDTGMNAVIAYSII	PCDH20	771	Q8N6Y1
QMGIAYFSIVAIVAK	OTOP3	426	Q7RTS5
SMQVYEGLDIITNKV	TRIT1	56	Q9H3H1
QLLAVASQVAAGMVY	NTRK1	626	P04629
YLVSIKVQSAGMTSE	PTPRB	1421	P23467
ANSMTALIVAVKGGY	KIDINS220	201	Q9ULH0
MVYLADVLKSNTTLE	LRRC34	311	Q8IZ02
IDALAVAYGVAMNKL	MAP3K10	306	Q02779
AATANYMEVVSLLKK	GPD2	241	P43304
VSSYMATVSGLLKIV	MYADML2	156	A6NDP7
ATAYGLIKSDAAMTV	KIT	606	P10721
MLTQKIAYQIASGLA	LRRK1	1361	Q38SD2
MGLKTYDALVIQNAS	MYO16	1191	Q9Y6X6
EGLMYLQENSAKVSA	GPC2	326	Q8N158
TDKLVNERLISMAYG	ATP1A1	841	P05023
GLLDVMYQVSKTSSV	LCORL	431	Q8N3X6
SVLMIEANGSILYKE	BMP15	366	O95972
LVSAVATEISQDKYM	FSIP2	6051	Q5CZC0
TKADIYSLGATLIHM	MAP3K8	306	P41279
NMGISVVSYTLKDIH	FLOT1	141	O75955
GNVLIMVTVASDKYL	OR4Q2	41	P0C623
LSSMADAVLARVYKQ	OTC	131	P00480
LSAMENLITYAVQKG	PGLYRP4	166	Q96LB8
LNDSKGEVLSVLYQM	DCSTAMP	186	Q9H295
LMLHTGKSADYVNLS	NRXN2	326	Q9P2S2
TGKTVSLLALIMAYQ	ERCC2	46	P18074
LKEVNISMYLVNGSV	LAMP2	296	P13473
MADKILSTGKYLNVV	TUBGCP2	446	Q9BSJ2
GTMATLSLVNEAQYL	MOCOS	726	Q96EN8
EGAMKIVNLLNDLYT	GUCY1B1	441	Q02153
MLGVYGVSNVTADLK	KIAA1549L	901	Q6ZVL6
VMNSKLGLDIEIATY	KRT82	406	Q9NSB4
KELEGALSTMVQLYS	LCN15	126	Q6UWW0
LMAGQIYDTVSLSAQ	LILRA6	316	Q6PI73
LMAGQIYDTVSLSAQ	LILRB3	316	O75022
YSKAAAVLAAESMVV	PDIA2	81	Q13087
TITVQGSAKATYLEM	MON2	456	Q7Z3U7
YQIKGMTANLAVLVA	NUDT7	186	P0C024
MGEQAVALARAVKYS	PCCA	316	P05165
SLSYVIQGMANIESL	FBXL14	81	Q8N1E6
KGAAMVTAVAYRLAE	HK1	451	P19367
TIKEVIYDMLNALAA	HUWE1	1941	Q7Z6Z7
QKALYSTAMESIQGE	PIP5K1A	356	Q99755
SGYISMKELKQALVN	PEF1	131	Q9UBV8
DYTDTLVSGKMALNL	PIK3CA	431	P42336
NLLVEKMDHVYGLST	MACF1	1136	Q9UPN3
ALYSKGILLMAASEN	NUP155	411	O75694
SSIAITALMEEKGYQ	RBBP6	451	Q7Z6E9
TLVISKEYTIGNAMT	ABCB4	321	P21439
TANLAAVMVGEKIYE	GRIN3A	761	Q8TCU5
AVYSALIQDGMKVIL	IL1RL2	471	Q9HB29
VAKRNIYLMDTSGKV	RPA1	341	P27694
MANVADTKLYDILGV	DNAJA2	1	O60884
YGMVAQVTQTLKLED	APOB	276	P04114
SILIAMNLAGAYNLK	CBLIF	56	P27352
GQMYSTAADLAKLAV	LACTBL1	251	A8MY62
MSDQTVRVKGAALKY	DOCK1	786	Q14185
DIKNGITNLLMYVKS	COG1	361	Q8WTW3
NLMNAVVLTVKASYV	CTNNA2	871	P26232
NTMTGDAIDYLVKNT	COL12A1	216	Q99715
AATAMAELKGYNLLL	DNAH3	561	Q8TD57
GEMIYQKVHSATLAI	DOK6	216	Q6PKX4
LIDSMSKQAIIYEGQ	EBF4	131	Q9BQW3
VDTGNVDSLKLLMYH	CTTNBP2	851	Q8WZ74
LTVGVYESAKLMNVD	GADD45B	36	O75293
VMTKIDSVAGINYGL	BPI	226	P17213
TAGLVYQEAGVLKMT	BPI	296	P17213
QGTLAQKYLEAMAVI	AXDND1	911	Q5T1B0
LQLVGTAAMLLASKY	CCNA1	286	P78396
QLSAYAMALKAVGEI	CPNE9	326	Q8IYJ1
TYELALQTGKVIEQM	DDX19B	171	Q9UMR2
LLVYAMTLVNKTLSG	FHOD3	261	Q2V2M9
NISMYELLKGNETIA	DENND5B	441	Q6ZUT9
VDLDMKGINYNSSVA	F11	116	P03951
KNQMDIATTLLEYGA	ANK3	641	Q12955
LIITMLNVSDSGVYQ	CNTN6	371	Q9UQ52
SQVMYLVVAAQAKAL	MACC1	341	Q6ZN28
LDVDNGNMYKSILVT	RALGDS	806	Q12967
KAVNDSMHLIAITGY	MCF2L	806	O15068
TDKLVNERLISMAYG	ATP1A3	831	P13637
IAYMDQASGNVKKAL	COL3A1	1376	P02461
AGALAYIMDNKLAQI	HLTF	116	Q14527
YIVEAGASLMKTDQQ	DGKZ	876	Q13574
NMYEDINIITGALKL	CHN1	331	P15882
ELITITMSGKVYANI	SLC15A1	496	P46059
LLIAAAVYIMDTVGN	SLC19A2	371	O60779
AMISYNIIAGDTLSK	SLC38A11	66	Q08AI6
VAALGGNAVVSYIMK	C2CD5	931	Q86YS7
LMQEKVLSAVTYAVD	CNST	136	Q6PJW8
ASYGQIILTVLQMKS	OR2AJ1	216	Q8NGZ0
LYGTSLEAIQAVMAK	MPP3	461	Q13368
ISGYLVDSVAKTMDA	MAP2K3	211	P46734
VLSSYTANLAAVMVG	GRIN3B	656	O60391
ALSSMANIAGYKAVV	NNT	191	Q13423
VAIQGVKASLYVAMN	FGF12	116	P61328
LVLSEADVSGMQSYK	TAAR3P	166	Q9P1P4
LNVTKVMYSGEETNL	USH2A	2381	O75445
AIAQGMETNELKYST	SORL1	551	Q92673
VAMAEALVTYKNSIK	CCT6B	416	Q92526
MAIFSVYVVNKAGGL	TRAPPC4	1	Q9Y296
IASIMENGSLNIYSV	TBC1D31	321	Q96DN5
GLANMVAQEALKYTV	TMCO4	331	Q5TGY1
SVISLQASYMGKENL	SYNE2	1556	Q8WXH0
QEYLAAVESSMKALL	SYNE2	2526	Q8WXH0
LVADMLLIQAYSAKI	SYNE2	4786	Q8WXH0
LMAVSTVVLQAFGKY	TMEM184B	186	Q9Y519
MVNDKGQVLIAASSY	TCAF2	41	A6NFQ2
LKTNDQMVVVYLASL	PSMD7	251	P51665
YVSEKIMKLAANISG	NIP7	46	Q9Y221
MAYLSENVSKHLGLS	HIF3A	106	Q9Y2N7
QNIGAMSSYLLIIKT	SLC38A6	131	Q8IZM9
GVSQVLSTYMKNLDI	STT3A	421	P46977
SISMGYKLQDLTDVQ	SLAIN1	261	Q8ND83
QSLMDLKDLGVAYIA	SETX	416	Q7Z333
LYISEVQLNTMAGAS	SLC25A36	41	Q96CQ1
IQQALIAAASMGYTE	TANC2	991	Q9HCD6
ITEKGISDLAQHYLM	CCT3	291	P49368
ASSGVMEKLQYASLL	SPATA16	451	Q9BXB7
DGMITLKVDNLTYRT	SRSF8	11	Q9BRL6
GIAMVDYLQKAVLLN	STXBP5	651	Q5T5C0
IATIKNISMSVEGDY	SUPT16H	551	Q9Y5B9
ALVVASASMSALYKV	SLC35F3	236	Q8IY50
VSDVAMKVLNSIAYK	RPTOR	826	Q8N122
MDLAQAGSTVESKIY	RRP12	601	Q5JTH9
GMTVKQAVLYNALSA	SLC39A6	651	Q13433
GYSFLVVLKAMTKNI	TMC1	286	Q8TDI8
MVTQASLYLLEATGK	CLCA1	56	A8K7I4
SSNYKVVLLGMDILS	CLASP1	61	Q7Z460
KVLSMGHLEEQLYAT	ULBP3	71	Q9BZM4
DGSATNKEYIQAMIL	SETDB2	41	Q96T68
TQGATEIVKLMISSY	TRPA1	281	O75762
VMLENYKNLIILAGS	ZNF846	36	Q147U1
AYLISKGQSVNMTDV	ZDHHC13	166	Q8IUH4
ASYQVGQDLTVMAAI	RHD	46	Q02161
ASYQVGQDLTVMAAL	RHCE	46	P18577
DLNLNVVAMALSGYT	MIOS	551	Q9NXC5
LMAIYTTENGIAEKS	SLC23A2	56	Q9UGH3
LAGLLSAMEYVQKTL	STAT3	221	P40763
KDVMLENYSNLVSLG	ZNF546	86	Q86UE3
YAKVSGVMDNNILVL	PRLR	546	P16471
MALYVLQALTATSQG	TMEM116	171	Q8NCL8
ALVNMGDLTTYDTVK	SLC25A27	201	O95847
YQAIAAKVGMDSTTV	SNX27	301	Q96L92
SAVMVLVNAVYFKGK	SERPINB7	166	O75635
YTDMSKVDGVLSLNV	VPS13C	1171	Q709C8
YAMKAVENSSTAIGI	PSMA3	26	P25788
KLLVNDMVVDSVGGY	ROS1	786	P08922
GYLSLHQTADVMTLK	SGSM1	276	Q2NKQ1
AKSTSAILIENMDLY	SUCO	326	Q9UBS9
SIVAYLIAKGQDVDM	ZDHHC17	171	Q8IUH5
IAAQMNDLAAKTVSY	TTC28	1066	Q96AY4
IKSYKANLNGMVISE	WDR76	291	Q9H967
ANLNGMVISEDTVYK	WDR76	296	Q9H967
VCNGKLYIVMEAAAT	TSSK6	81	Q9BXA6
KALLYTAVNQLAMGS	TTC37	1231	Q6PGP7
AVLQAATGMYEQLKG	PSMD8	86	P48556
QKTISAYIKMVDAAL	WSCD2	536	Q2TBF2
TVGVLLAAKMSQYAN	SEC31A	741	O94979
IVYLGAKGTTAAQMA	SERPINB10	41	P48595
ILVIKAAEDSALQYM	GTF2H3	161	Q13889
LKGQMIYIVESSAIL	GUCY1A1	366	Q02108
VAVAELLSMKIPNSY	KMT2D	4801	O14686
LQLVKGAMAATYSAL	RPS6KA1	691	Q15418
QIIGANMSTYLLEKS	MYO5C	231	Q9NQX4
SLETLNHSVLKAMGY	NECAB2	136	Q7Z6G3